World Journal of Gastrointestinal Surgery - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 27

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

181

HTML

2347

Sum=2528

Publishing Process of This Article

Item

Count

Browse

169

Download

470

Sum=639

Jul 21, 2024 (publication date) through Dec 19, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	McGinty G, Przemioslo R. Effects of excess high-normal alanine aminotransferase levels in relation to new-onset metabolic dysfunction-associated fatty liver disease: Clinical implications. World J Gastroenterol 2024; 30(27): 3264-3267 [PMID: 39086753 DOI: 10.3748/wjg.v30.i27.3264]
URL:	https://www.wjgnet.com/1948-9366/full/v30/i27/3264.htm

Number	Citing Articles
1	Ling Luo, Congxiang Shao, Long Teng, Shuyu Zhuo, Zhi Dong, Wei Wang, Junzhao Ye, Bihui Zhong. Liver fibrosis with persistently normal alanine transaminase levels exhibits a distinct treatment response in MASLD. BMJ Open Gastroenterology 2025; 12(1): e001895 doi: 10.1136/bmjgast-2025-001895
2	Terence N Moyana. Metabolic dysfunction-associated steatotic liver disease: The question of long-term high-normal alanine aminotransferase as a screening test. World Journal of Gastroenterology 2024; 30(42): 4576-4582 doi: 10.3748/wjg.v30.i42.4576 Abstract(529) \| Core Tip(605) \| Full Article(HTML)(1716) \| Full Article with Cover (PDF)-644K(275) \| Audio-887K(7) \| Peer-Review Report-177K(96) \| Answering Reviewers-110K(93) \| Full Article (PDF)-421K(116) \| Full Article (XML)-115K(83) \| Times Cited (2) \| Total Visits (4017) \| Open
3	Can Huang, Meng Chen, Yanfang Sun, Lin Zhang, Wei Liu. Research trends on the quality of life in patients with metabolic dysfunction-associated fatty liver diseases: a scientific metrology study. Frontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1689280
4	Zhi Peng, Zijin Wang, Juan Wang, Xuefeng Li. Hepatic steatosis/fibrosis related biomarkers in patients with metabolic dysfunction-associated steatotic liver disease. Biomarkers in Medicine 2025; : 1 doi: 10.1080/17520363.2025.2595909